{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T21:29:59Z","timestamp":1765229399136,"version":"3.46.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To explore tumor characteristics and prior liver treatment associated with lung shunt fraction (LSF) during technetium-99\u2005m (\n                      <jats:sup>99m<\/jats:sup>\n                      Tc)-macroaggregated albumin (MAA) imaging for patients with hepatic malignancies who are to undergo yttrium-90 radioembolization.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Patients with hepatic malignancies who underwent transarterial\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-MAA single photon emission computed tomography\/computed tomography (CT) imaging by consulting\n                      <jats:sup>90<\/jats:sup>\n                      Y microspheres for treatment from September 2021 to February 2025 at the Vascular and Interventional Surgery Department of Zhongda Hospital Southeast University were collected. All patients underwent contrast-enhanced CT or MRI for evaluation before hepatic angiography.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of these 113 patients, with a median age of 60 years, were enrolled in this study. In the high LSF group, the tumor volume (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001), perfusion volume (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.040), and 100INR (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001) were significantly higher in these patients than in the other groups; for these patients, serum albumin was significantly lower than that in the other two groups (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001). There was a significant difference in LSF between the hepatic vein (HV) groups; the highest LSF was found in such patients with clear evidence of tumor thrombus in the HV (median LSF = 26.50%), which was significantly higher than that in the group with HV invasion and the normal group (respectively, median LSF = 14.08 and 6.55%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001); whereas, portal vein did not have any effect on the LSF level (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.445).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Tumor data, liver function indexes, and specific treatment history are associated with higher LSF and indicate the need for interventions to reduce it.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mnm.0000000000002010","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:00:19Z","timestamp":1751605219000},"page":"801-808","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Factors influencing lung shunt fraction on 99mTc-MAA SPECT\/computed tomography imaging in patients with hepatic malignancies for yttrium-90 microspheres embolization"],"prefix":"10.1097","volume":"46","author":[{"given":"Xinyu","family":"Wang","sequence":"first","affiliation":[{"name":"Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Nuclear Medicine, School of Medicine, Zhongda Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijie","family":"Du","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, School of Medicine, Zhongda Hospital, Southeast University, Nanjing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiacheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Nuclear Medicine, School of Medicine, Zhongda Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"R1-20251208","doi-asserted-by":"crossref","first-page":"120","DOI":"10.3389\/fonc.2014.00120","article-title":"Yttrium-90 radioembolization of hepatic metastases from colorectal cancer.","volume":"4","author":"Raval","year":"2014","journal-title":"Front Oncol"},{"key":"R2-20251208","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1053\/j.tvir.2007.08.001","article-title":"Technical aspects of radioembolization with 90Y microspheres.","volume":"10","author":"Salem","year":"2007","journal-title":"Tech Vasc Interv Radiol"},{"key":"R3-20251208","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1148\/rg.281075115","article-title":"Recent advances in transarterial therapy of primary and secondary liver malignancies.","volume":"28","author":"Kalva","year":"2008","journal-title":"Radiographics"},{"key":"R4-20251208","doi-asserted-by":"crossref","first-page":"106094","DOI":"10.1016\/j.ijsu.2021.106094","article-title":"Clinical consensus statement: selective internal radiation therapy with yttrium 90 resin microspheres for hepatocellular carcinoma in Asia.","volume":"102","author":"Liu","year":"2022","journal-title":"Int J Surg"},{"key":"R5-20251208","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/BF01084369","article-title":"Partition model for estimating radiation doses from yttrium-90 microspheres in treating hepatic tumours.","volume":"23","author":"Ho","year":"1996","journal-title":"Eur J Nucl Med"},{"key":"R6-20251208","first-page":"293","article-title":"Clinicalevaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancer.","volume":"24","author":"Ho","year":"1997","journal-title":"Eur J Nucl Med"},{"key":"R8-20251208","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1148\/radiol.14131969","article-title":"Characteristics of primary and secondary hepatic malignancies associated with hepatopulmonary shunting.","volume":"271","author":"Gaba","year":"2014","journal-title":"Radiology"},{"key":"R9-20251208","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/j.jvir.2015.07.009","article-title":"Imaging predictors of elevated lung shunt fraction in patients being considered for yttrium-90 radioembolization.","volume":"26","author":"Olorunsola","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"R10-20251208","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00270-017-1619-z","article-title":"Indicators of lung shunt fraction determined by technetium-99m macroaggregated albuminin patients with hepatocellular carcinoma.","volume":"40","author":"Kallini","year":"2017","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R11-20251208","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s00270-022-03283-z","article-title":"Reduction of hepatopulmonary and intrahepatic shunts after treatment with sorafenib in hepatocellular carcinoma patients.","volume":"45","author":"Balli","year":"2022","journal-title":"Cardiovasc Intervent Radiol"},{"key":"R12-20251208","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/jcp.21172","article-title":"Liver regeneration.","volume":"213","author":"Michalopoulos","year":"2007","journal-title":"J Cell Physiol"},{"key":"R13-20251208","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.gendis.2023.01.030","article-title":"Canonical and noncanonical Wnt signaling: multilayered mediators, signaling mechanisms and major signaling crosstalk.","volume":"11","author":"Qin","year":"2023","journal-title":"Genes Dis"},{"key":"R14-20251208","first-page":"156","article-title":"Role of Ang II on the activation and proliferation of hepatic stellate cell LX2 through activation of Notch1\/Sox2 pathway.","volume":"08","author":"Zheng","year":"2018","journal-title":"Chin J Cell Stem Cell (Electron Ed)"},{"key":"R15-20251208","first-page":"323","article-title":"Mechanisms of activated state hepatic stellate cells promoting neovascularization in hepatocellular carcinoma.","volume":"5","author":"Tang","year":"2016","journal-title":"Chin Electron J Liver Sur"},{"key":"R16-20251208","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s00441-016-2443-5","article-title":"Portal myofibroblasts connect angiogenesis and fibrosis in liver.","volume":"365","author":"Lemoinne","year":"2016","journal-title":"Cell Tissue Res"},{"key":"R17-20251208","first-page":"237","article-title":"Clinical significance of coagulation and anticoagulation index monitoring in various types of liver diseases.","volume":"26","author":"Qian","year":"2016","journal-title":"J Integr Chin Western Med Liver Disease"},{"key":"R18-20251208","doi-asserted-by":"crossref","first-page":"240","DOI":"10.5114\/ceh.2018.80125","article-title":"Predictive power of model for end-stage liver disease and child-turcotte- pugh score for mortality in cirrhotic patients.","volume":"4","author":"Piotrowski","year":"2018","journal-title":"Clin Exp Hepatol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,8]],"date-time":"2025-12-08T20:00:29Z","timestamp":1765224029000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MNM.0000000000002010"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":17,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0000000000002010","relation":{},"ISSN":["0143-3636","1473-5628"],"issn-type":[{"type":"print","value":"0143-3636"},{"type":"electronic","value":"1473-5628"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}